Literature DB >> 12086271

Epidemiology of giant-cell arteritis.

Gene G Hunder1.   

Abstract

Entities:  

Mesh：

Year:  2002        PMID： 12086271     DOI： 10.3949/ccjm.69.suppl_2.sii79

Source DB:  PubMed          Journal:  Cleve Clin J Med        ISSN： 0891-1150            Impact factor:   2.321


× No keyword cloud information.
  12 in total

1.  Lower body mass index is associated with a higher risk of giant cell arteritis: a systematic review and meta-analysis.

Authors:  Patompong Ungprasert; Charat Thongprayoon; Kenneth J Warrington
Journal:  Ann Transl Med       Date:  2015-09

2.  [Giant cell arteritis: etiological knowledge and diagnostic challenge for pathologists].

Authors:  S C Schaefer; H A Lehr
Journal:  Pathologe       Date:  2012-05       Impact factor: 1.011

3.  Ophthalmic presentation of giant cell arteritis in African-Americans.

Authors:  S T Garrity; M Pistilli; M S Vaphiades; N Q Richards; P S Subramanian; P R Rosa; B L Lam; B J Osborne; G T Liu; K E Duncan; R K Shin; N J Volpe; K S Shindler; M S Lee; M L Moster; E H Tracey; S E Cuprill-Nilson; M A Tamhankar
Journal:  Eye (Lond)       Date:  2016-09-16       Impact factor: 3.775

Review 4.  The treatment of giant cell arteritis.

Authors:  J Alexander Fraser; Cornelia M Weyand; Nancy J Newman; Valérie Biousse
Journal:  Rev Neurol Dis       Date:  2008

5.  Effect of diabetes mellitus on giant cell arteritis.

Authors:  Anne S Abel; Arseniy P Yashkin; Frank A Sloan; Michael S Lee
Journal:  J Neuroophthalmol       Date:  2015-06       Impact factor: 3.042

Review 6.  Evidence-based Role of Aspirin in Giant Cell Arteritis: A Literature Review.

Authors:  Anum Qureshi; Fatima Halilu; Sam W Serafi; Howard Hauptman; Tristan Flack
Journal:  J Community Hosp Intern Med Perspect       Date:  2022-09-09

7.  Incidence of diagnosed polymyalgia rheumatica and temporal arteritis in the United Kingdom, 1990-2001.

Authors:  L Smeeth; C Cook; A J Hall
Journal:  Ann Rheum Dis       Date:  2006-01-13       Impact factor: 19.103

8.  Assessment of the efficacy and safety of tocilizumab in patients over 80 years old with giant cell arteritis.

Authors:  Hubert de Boysson; Maelle Le Besnerais; Félix Blaison; Aurélie Daumas; Pierre-André Jarrot; François Perrin; Nathalie Tieulié; Alexandre Maria; Pierre Duffau; Bruno Gombert; Maxime Samson; Olivier Espitia; Marc Lambert; Arsène Mékinian; Achille Aouba
Journal:  Arthritis Res Ther       Date:  2021-05-19       Impact factor: 5.156

9.  Identification of target antigens of anti-endothelial cell and anti-vascular smooth muscle cell antibodies in patients with giant cell arteritis: a proteomic approach.

Authors:  Alexis Régent; Hanadi Dib; Kim H Ly; Christian Agard; Mathieu C Tamby; Nicolas Tamas; Babette Weksler; Christian Federici; Cédric Broussard; Loïc Guillevin; Luc Mouthon
Journal:  Arthritis Res Ther       Date:  2011-06-28       Impact factor: 5.156

10.  Bitemporal scalp, lip and tongue necrosis in giant cell arteritis: a rare presentation.

Authors:  Rajesh Kumar; Hemant Gupta; Anil Jadhav; Sv Khadilkar
Journal:  Indian J Dermatol       Date:  2013-07       Impact factor: 1.494
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.